HIGHLIGHTS
- who: Haixia Zhang and colleagues from the Osaka University, Japan have published the Article: Role of the CCL2-CCR2 axis in cardiovascular disease: Pathogenesis and clinical implications, in the Journal: (JOURNAL)
SUMMARY
Cardiovascular disease is the world' s leading cause of morbidity and mortality. A rising body of evidence suggests that inflammation is a key contributor to cardiovascular disease. Randomized clinical trials based on canakinumab and colchicine have evidenced the effectiveness of particular anti-inflammatory treatments in the field of cardiovascular disease prevention. Chemokines and its receptors have been described as essential mediators . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.